German Manufacturing Scale Takeda Deutschland operates two production sites in Singen and Oranienburg within a global pharmaceutical network. The sites manufacture liquid, semi-solid, freeze-dried, and solid dosage forms, signaling strong local manufacturing capacity suitable for contract manufacturing, fill-finish, and regional supply partnerships.

Therapy & R&D Focus Core research focuses on Oncology, Rare Genetic Diseases & Hematology, Neuroscience, and Gastroenterology, with targeted investments in plasmabased therapies and vaccines. This creates opportunities for co-development, licensing, and Germany-based market access collaborations.

ESG & Patient-Centricity Takeda emphasizes integrity, fairness, honesty and perseverance, with commitments to patients, employees and the environment. This ESG and patient-centric ethos supports compliant, outcome-driven partnerships aligned with sustainable healthcare in Germany.

Awards & Readiness Top honors in the 2022 Facility of the Year Awards in Supply Chain and Pharma 4.0 reflect strong operational maturity. A mid-range revenue footprint signals capacity to support regional manufacturing, distribution, and co-development initiatives.

Local Footprint & Partnerships With a Berlin headquarters and four decades of German presence, Takeda Germany offers a solid local footprint and a history of collaborations, making it a viable partner for licensing, co-development, and strategic alliances in the German market.